{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:45Z","timestamp":1772119485263,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Bank"],"DOI":"10.1007\/s10561-025-10193-0","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:48:28Z","timestamp":1757324908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased serologic reactivity with automated CMIA testing and its implications for deceased donor eligibility determination in the United States"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6373-7962","authenticated-orcid":false,"given":"Sara O.","family":"Dionne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1516-3048","authenticated-orcid":false,"given":"Hillary C. S. R.","family":"Akana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7315-1539","authenticated-orcid":false,"given":"Kimberly A.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6923-2107","authenticated-orcid":false,"given":"Brenden R.","family":"O\u2019Neale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"10193_CR1","unstructured":"Association for Advancing Tissue & Biotherapies. Donor History Questionnaires. Accessed 10 Jul 2025."},{"issue":"2","key":"10193_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10561-011-9252-6","volume":"13","author":"C Baleriola","year":"2012","unstructured":"Baleriola C, Johal H, Robertson P, Jacka B, Whybin R, Taylor P, Rawlinson WD (2012) Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens. Cell Tissue Bank 13(2):251\u2013258. https:\/\/doi.org\/10.1007\/s10561-011-9252-6","journal-title":"Cell Tissue Bank"},{"key":"10193_CR3","volume-title":"Immunoassay interference and performance characteristics","author":"CLSI","year":"2018","unstructured":"CLSI (2018) Immunoassay interference and performance characteristics, 3rd edn. CLSI EP07","edition":"3"},{"key":"10193_CR4","unstructured":"eCFR:: 21 CFR Part 1271\u2014Human Cells, Tissues, and Cellular and Tissue-Based Products Accessed 29 Mar 2025. American Association of Tissue Banks STANDARDS FOR TISSUE BANKING Copyright \u00ae 2016."},{"key":"10193_CR5","unstructured":"eCFR:: 21 CFR Part 1271 Subpart C\u2014Donor Eligibility. Accessed 29 Mar 2025."},{"issue":"1","key":"10193_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23033","volume":"34","author":"P Fu","year":"2020","unstructured":"Fu P, Devare S, Liu JF, Lv XT, Yin P, Wu BT, Ke L, Liu Y, Shan H (2020) Evaluate performance of the Abbott chemiluminescent microparticle immunoassay assay for detection of syphilis infection in Chinese blood donors. J Clin Lab Anal 34(1):e23033. https:\/\/doi.org\/10.1002\/jcla.23033","journal-title":"J Clin Lab Anal"},{"issue":"18","key":"10193_CR7","first-page":"362","volume":"62","author":"JP Getchell","year":"2013","unstructured":"Getchell JP et al (2013) Testing for HCV infection: an update of guidance for clinicians and laboratorians. Morbidity Mort Weekly Rep 62(18):362\u2013365","journal-title":"Morbidity Mort Weekly Rep"},{"key":"10193_CR8","unstructured":"Guidance for Industry: Recommendations for Obtaining a Labeling Claim for Communicable Disease Donor Screening Tests Using Cadaveric Blood Specimens from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT\/Ps). https:\/\/www.fda.gov\/media\/73121\/download. Accessed 5 Aug 2025."},{"issue":"6","key":"10193_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000524250","volume":"49","author":"N Kohmer","year":"2022","unstructured":"Kohmer N, Kortenbusch M, Berger A, R\u00fchl C, Ciesek S, Salla S, Rabenau HF (2022) Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors. Transfus Med Hemother 49(6):379\u2013387. https:\/\/doi.org\/10.1159\/000524250","journal-title":"Transfus Med Hemother"},{"key":"10193_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10561-020-09810-x","volume":"21","author":"CC Kok","year":"2020","unstructured":"Kok CC, Ramachandran V, Egilmezer E, Ray S, Walker GJ, Rawlinson WD (2020) Serological testing for infectious diseases markers of donor specimens from 24 h after death show no significant change in outcomes from other specimens. Cell Tissue Bank 21:171\u2013179","journal-title":"Cell Tissue Bank"},{"key":"10193_CR11","volume-title":"Henry's clinical diagnosis and management by laboratory methods","author":"RA McPherson","year":"2016","unstructured":"McPherson RA, Pincus MR (2016) Henry\u2019s clinical diagnosis and management by laboratory methods, 23rd edn. Elsevier","edition":"23"},{"key":"10193_CR12","unstructured":"NTRUS Results Reveal Trends in Tissue|American Association of Tissue Banks (5 Apr 2018). https:\/\/www.aatb.org\/news\/ntrus-results-reveal-trends-tissue. Accessed May 20, 2025."},{"key":"10193_CR13","unstructured":"Reference Tool to Determine Hemolysis Status. https:\/\/www.cdc.gov\/vector-borne-diseases\/php\/laboratories\/reference-tool-for-hemolysis-status.html. Accessed 17 Aug 2025."},{"key":"10193_CR14","unstructured":"Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations (2009). World Health Organization, Geneva. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK142990"},{"key":"10193_CR15","unstructured":"Testing Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT\/P) Donors for Relevant Communicable Disease Agents and Diseases|FDA. Accessed 29 Mar 2025."},{"key":"10193_CR16","unstructured":"U.S. Food and Drug Administration (2007) Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT\/Ps). Washington, DC: U.S. Department of Health and Human Services, Food and Drug Administration"},{"key":"10193_CR17","unstructured":"U.S. Food and Drug Administration. 21 CFR \u00a71271.50\u2014How do I determine whether a donor is eligible? Electronic Code of Federal Regulations. Updated regularly. Accessed 10 Jul 2025. https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-L\/part-1271\/section-1271.50"},{"issue":"1","key":"10193_CR18","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1097\/TXD.0000000000000852","volume":"5","author":"SL White","year":"2019","unstructured":"White SL et al (2019) Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission. Transplant Direct 5(1):e416. https:\/\/doi.org\/10.1097\/TXD.0000000000000852","journal-title":"Transplant Direct"},{"key":"10193_CR19","unstructured":"World Health Organization (2010) Screening donated blood for transfusion-transmissible infections: recommendations."},{"issue":"2","key":"10193_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpha.2011.10.001","volume":"2","author":"QY Zhang","year":"2012","unstructured":"Zhang QY, Chen H, Lin Z, Lin JM (2012) Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum \u03b1-fetoprotein. J Pharm Anal 2(2):130\u2013135. https:\/\/doi.org\/10.1016\/j.jpha.2011.10.001","journal-title":"J Pharm Anal"}],"container-title":["Cell and Tissue Banking"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10561-025-10193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10561-025-10193-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10561-025-10193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:14:34Z","timestamp":1759140874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10561-025-10193-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["10193"],"URL":"https:\/\/doi.org\/10.1007\/s10561-025-10193-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7141248\/v1","asserted-by":"object"}]},"ISSN":["1573-6814"],"issn-type":[{"value":"1573-6814","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"40"}}